Global Celiac Disease Treatment Market
Pharmaceuticals

Celiac Disease Treatment Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Estimated Market Size of the Celiac Disease Treatment Market In 2029?

The size of the market for celiac disease treatment has experienced considerable growth in the past few years. Its growth predicts a surge from $0.61 billion in 2024 to $0.67 billion in 2025, with a remarkable compound annual growth rate (CAGR) of 9.9%. This historic growth has been driven by factors such as a higher occurrence of celiac disease, an increase in awareness and diagnostic rates, a surge in demand for treatment options beyond diet, a robust pipeline of innovative therapies, encouraging initiatives from regulatory bodies and an upswing in investment from pharmaceutical corporations.

Strong expansion is anticipated in the celiac disease treatment market size over the forthcoming years, with an expected growth to reach $0.96 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.6%. The rise during the projected period can be ascribed to factors such as an escalating global incidence of celiac disease, increased recognition and diagnosis rates, ongoing clinical explorations for new treatments, rising demand for gluten-free alternatives, favorable regulatory initiatives for orphan diseases, and an increase in healthcare spending. Key trends in the forecast period encompass the implementation of innovative non-dietary therapies, advances in enzyme supplements, personalised medicine strategies, the formation of peptide-based immunotherapies, enhanced diagnostic tools, and progress in clinical trials.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

What External and Internal Drivers Are Contributing to the Growth of the Celiac Disease Treatment Market?

The escalating prevalence of diabetes is predicted to stimulate the expansion of the celiac disease treatment market. Diabetes, a persistent health issue, arises when the body fails to adequately balance blood sugar or glucose levels. The growing incidence of diabetes stems from common dietary control needs since both diseases necessitate a strict supervision of food consumption to regulate blood sugar levels and avoid complications. Treatment for celiac disease aids diabetes management by encouraging a gluten-free diet, which can enhance overall digestive health and nutrient absorption. This leads to improved blood sugar regulation and lessens complications for individuals handling both diseases. For example, in June 2024, the National Health Service, a government department in the UK, reported that approximately 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023. This was an 18% rise from 3,065,825 cases in 2022. Hence, the escalating prevalence of diabetes is a crucial factor propelling the celiac disease treatment market’s growth.

What Segment Types Define the Celiac Disease Treatment Market Structure?

The celiac disease treatment market covered in this report is segmented –

1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments

2) By Enzyme Type: Distension, Diarrhoea, Anorexia, Bloating, Gas, Fatigue

3) By Diagnosis: Serological Tests, Genetic Testing, Biopsy

4) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels

Subsegments:

1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins

2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations

3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents

4) By Other Treatments: Probiotics, Immunotherapy, Stem Cell Therapy, Experimental Therapies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Celiac Disease Treatment Market?

North America was the largest region in the celiac disease treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Long-Term Trends Are Transforming the Competitive Landscape of the Celiac Disease Treatment Market?

Leading organizations working within the market for celiac disease treatment are focusing their efforts on the development of oral treatments, including small molecule therapies. These treatments provide targeted relief by inhibiting the immune response to gluten, thereby increasing patient compliance and providing alternatives to stringent gluten-free diets. Small molecule therapies are minuscule drugs designed to penetrate cells with ease in order to target and treat disease-causing proteins or enzymes. For example, Immunic Inc., a biotech firm based in the U.S., introduced IMU-856 in February 2025. This small molecule raises the levels of endogenous glucagon-like peptide-1 (GLP-1), aiding in strengthening intestinal barrier functionality for individuals suffering from celiac disease. Additionally, it enhances nutrient absorption and alleviates symptoms without negatively impacting immune activity.

View the full report here:

https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report

What Is the Definition of the Celiac Disease Treatment Market?

Celiac disease treatment involves managing the Celiac disease, an autoimmune reaction to gluten that damages the small intestine and impairs nutrient absorption by following a strict gluten-free diet. It avoids foods and products containing wheat, barley, rye, and other gluten-containing grains. Celiac disease treatment reduces symptoms, heals the lining of the small intestine, and prevents long-term health issues.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/customise?id=24186&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model